Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
Program letter encourages public health partners and grant recipients to implement status neutral approaches to HIV care and prevention.News Article updated on 01/18/2023
-
Ryan White Conference Database Expands
A searchable database is now available to access slides and videos from HRSA Ryan White Conferences stretching back to 2020.Blog updated 03/28/2024
-
HIV Clinical Pharmacist Services
The HIV Clinical Pharmacist Services intervention shortens the time between referral to and engagement in care by allowing newly referred clients to see pharmacists in addition to other clinical providers for their initial appointment. This intervention is supported by findings from a retrospective cohort study that took place from 2013 to 2017 at a RWHAP-funded clinic. In addition to significantly decreasing the time between referral and initial visit, clients who saw a pharmacist also experienced shortened time to antiretroviral therapy initiation and viral suppression compared to those who only saw non-pharmacist providers.Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
-
Medicare Enrollment and Coverage for Ryan White HIV/AIDS Program (RWHAP) Clients
Best practices for providing Medicare enrollment support.Resource updated 03/11/2024
-
Mpox Emergency is Over
The mpox emergency declaration ended at the end of January 2023.News Article updated on 02/02/2023 -
Simplifying Salvage Antiretroviral Regimens in Treatment-Experienced PLWH
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
-
HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
-
Applying technological innovation: Harnessing an electronic patient portal to achieve a patient-centered approach to recertification
Using a multidisciplinary approach to harness the electronic patient portal for completion of RWHAP six-month recertification documents, we were able to create a more patient-centered method that complies with program requirements. We will discuss the challenges, opportunities, and results of using such technology in program recertification.
Resource (Conference Presentation) updated 09/14/2023
-
The Max Clinic: A multi-agency collaborative approach to addressing the complex health and social needs of people living with HIV in Tacoma, WA.
Max Clinic's multi-agency partnership to address the complex medical and social needs of people with HIV by utilizing a multidisciplinary approach involving case management, field work, and comprehensive medical services to reach people with HIV who are not currently engaged in HIV care.
Resource (Conference Presentation) updated 09/14/2023
-
Promising Practices: The Impact of COVID-19 Related Policy Changes On Enrollment Capacity Within California's ADAP
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
-
Assessing Medication Access Barriers in Patients Living with HIV
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
-
Listening Session on Policy Clarification Notice 16-02 Ryan White HIV/AIDS Program Services: Eligible Individuals and Allowable Uses of Funds
Listening Session on how Policy Clarification Notice 16-02 and how the HRSA HAB RWHAP service categories and allowable uses of funds can be refreshed to best reflect new and emerging needs, science, and service delivery models.
Resource (Conference Presentation) updated 09/14/2023
-
Community Co-Creation: Engaging Traditional and Nontraditional Partners in a National Viral Suppression Campaign
HHS process for development of the “I Am a Work of ART” viral suppression campaign, in collaboration with community partners. of the National HIV/AIDS Strategy.
Resource (Conference Presentation) updated 09/14/2023
-
National HIV Curriculum 3rd Edition Launched
After extensive reviews and updates, the National HIV Curriculum 3rd Edition launched on September 1 to start a new 3-year CE accreditation period.News Article updated on 09/27/2023 -
Integration of Buprenorphine into HIV Primary Care Settings Toolkit
Overview of training manual, curriculum, and webinars related to on integrating opioid addiction treatment using buprenorphine.Informational updated 04/03/2024
-
Enhancing HIV Care of Women, Infants, Children and Youth: Building Capacity through Communities of Practice
Platform for RWHAP Part D recipients to increase the delivery of care innovations; increase the skills of staffing working with women, infant, children and youth; and support partner collaboration for dissemination of best practices.RWHAP Technical Assistance Provider updated on 05/24/2024
-
RWHAP Program Letter: ADAPs and SUD Medications
On May 11, HRSA’s HIV/AIDS Bureau released a program letter encouraging RWHAP ADAP recipients to include medications for SUDs, including buprenorphine for OUD, and naloxone for opioid overdose prevention, on ADAP formularies.News Article updated on 05/15/2023 -
Program Letter: Role of RWHAP in Addressing STIs and Mpox
State AIDS Drug Assistance Programs (ADAPs), which provide medications for people with HIV who lack health coverage. play "a critical role in addressing STIs for people with HIV"News Article updated on 05/24/2023 -
Long-Acting Injectables for HIV Antiretroviral Therapy
Guide for EHE jurisdictions on what they can do to enhance implementation of long-acting injectable antiretroviral therapy.Resource updated 04/12/2024
-
STI Implementation Plan Released
HHS has released an implementation plan on specific actions for entities to take in preventing and treating sexually transmitted infections (STI).News Article updated on 06/13/2023